Contract manufacturing for Irish brands

Ireland is a 5 million-person market with Dublin as its administrative capital and Dublin as its largest commercial city. Key commercial cities include Dublin, Cork, Galway, Limerick, Waterford. The working language for label artwork, regulatory submission and retail packaging is English (Irish/Gaeilge bilingual labelling optional). Retail distribution flows through Boots Ireland, Hickey's Pharmacy, Holland & Barrett, Dunnes and Tesco Ireland, and an English-language DTC market with cross-border to the UK. On the supplement industry signal: English-language EU artwork + pharma cluster (Pfizer, Lilly) + Glanbia HQ. For brand owners briefing DAT Supply, Ireland is positioned as a regulated EU food-supplement market: artwork is produced in English (Irish/Gaeilge bilingual labelling optional), the food business operator (typically the brand owner) carries label responsibility under the EU Reg. 1169/2011 framework, and the notification is filed with the country's competent authority (see the Regulatory framework section). DAT coordinates manufacturing, documentation and shipping under a single project so the brand owner can focus on demand generation, retail placement and the post-launch reorder cycle. The country's neighbours and natural cross-launch pairs for a single artwork project are listed under the internal links below.

Dietary supplements in Ireland are regulated as a category of food. The framework rests on EU Directive 2002/46/EC (food supplements), EU Reg. 1169/2011 (food information to consumers) and EU Reg. 1924/2006 / 432/2012 (nutrition and health claims), transposed nationally as EU Reg. 1924/2006 and 1169/2011, plus the FSAI notification scheme under the Food Safety Authority of Ireland. Notification authority and route: FSAI. FSAI notification. The brand owner is the food business operator and carries label responsibility — DAT supplies the documentation pack but does not file on the brand owner's behalf. Label-language requirement: English (Irish/Gaeilge optional). Allergen labelling: EU FIC 1169/2011 allergens in English with bold emphasis. Novel ingredients: the EU novel food catalogue applies. Claim wording is the most-reviewed surface of the artwork pack. Permitted health claims are drawn from the applicable claims framework register and any on-hold claims awaiting EFSA opinion; structure-function copy that does not assert disease prevention, treatment or cure is reviewed against the boundary set by Article 7 of Reg. 1169/2011 and the national authority's published guidance. Common rejection patterns: (i) implied disease-treatment phrasing on energy, sleep or stress SKUs, (ii) un-permitted comparative claims against medicines, (iii) using authorised-claim wording on products that do not meet the conditions of use, and (iv) translated claim wording that drifts from the authorised phrasing. DAT's artwork gate cross-references every claim on the pack against the authorised register or the national authority's borderline guidance before the brand owner files. Distinctive Ireland signal: FSAI notification typically receives an acknowledgement; common practice is to use the same artwork base as the UK with regulatory variant for EU FIC. Certification panel commonly seen on Ireland pack: V-Label, IOFGA / EU organic leaf, kosher / halal where the brief requires it. Where certification is desired the brand owner provides the certificate and DAT confirms compliance against the certifier's scheme during the documentation pack assembly. Retailer-specific documentation expectations: pharmacy, drugstore and grocery buyers commonly request the technical dossier (formulation specification, raw-material specifications, microbiological release criteria, stability summary, allergen statement, country-of-origin declaration, certificate of GMP-aligned manufacturing) before listing a new SKU. DAT supplies the dossier as a single packaged set so the brand owner can present a complete file at the listing meeting. Post-launch obligations: the food business operator records and investigates any adverse events through the national vigilance route, maintains the technical file for the legal retention period (commonly five years from last batch shelf life), and keeps the artwork in step with any future authoritative re-interpretation of claim wording on the authorised register. DAT supports the brand owner through batch-by-batch documentation and an artwork variant track when the register changes.

Notification authority: FSAI